Bio-Path Holdings, Inc. (BPTH)
NCM · Common · CUSIP 09057N409
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BPTH and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09057N409 (prev. 04744L106 )
Market Cap
Small Cap
Business: Bio-Path Holdings, Inc. is a biotechnology company developing targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers.

Company Contact

CEO
Sam Ash
CFO
Gerbrand Van Heerden
Headquarters
4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401
Phone
832-742-1357
Investor Relations
Doug Morris · 832-742-1369 · dmorris@biopathholdings.com
SEC EDGAR Filings
View filings »